Expression of NRF2-AKR1C signaling components has been analysed in paediatric T-ALL samples endowed with different treatment outcomes as well as in patient-derived xenografts of T-ALL. The gene discussed is NFE2L2; the disease is acute lymphoblastic leukemia.